| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | aspartic-type endopeptidase activity | 1.81e-05 | 37 | 85 | 4 | GO:0004190 | |
| GeneOntologyMolecularFunction | aspartic-type peptidase activity | 2.02e-05 | 38 | 85 | 4 | GO:0070001 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity | 4.35e-05 | 46 | 85 | 4 | GO:0005245 | |
| GeneOntologyMolecularFunction | CCR4-NOT complex binding | 5.36e-05 | 3 | 85 | 2 | GO:1905762 | |
| GeneOntologyMolecularFunction | proteoglycan binding | 6.56e-05 | 51 | 85 | 4 | GO:0043394 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity | 1.27e-04 | 182 | 85 | 6 | GO:0005244 | |
| GeneOntologyMolecularFunction | voltage-gated channel activity | 1.35e-04 | 184 | 85 | 6 | GO:0022832 | |
| GeneOntologyMolecularFunction | calcium channel activity | 2.26e-04 | 129 | 85 | 5 | GO:0005262 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 4.67e-04 | 151 | 85 | 5 | GO:0015085 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic cation channel activity | 4.81e-04 | 152 | 85 | 5 | GO:0022843 | |
| GeneOntologyMolecularFunction | gated channel activity | 5.56e-04 | 334 | 85 | 7 | GO:0022836 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | 6.50e-04 | 343 | 85 | 7 | GO:0005261 | |
| GeneOntologyMolecularFunction | amyloid-beta binding | 9.46e-04 | 102 | 85 | 4 | GO:0001540 | |
| GeneOntologyMolecularFunction | glycosaminoglycan binding | 9.97e-04 | 268 | 85 | 6 | GO:0005539 | |
| GeneOntologyMolecularFunction | complement component C3b binding | 1.15e-03 | 12 | 85 | 2 | GO:0001851 | |
| GeneOntologyMolecularFunction | glutamate binding | 1.58e-03 | 14 | 85 | 2 | GO:0016595 | |
| GeneOntologyMolecularFunction | carbohydrate binding | 2.09e-03 | 310 | 85 | 6 | GO:0030246 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein tyrosine phosphatase activity | 2.34e-03 | 17 | 85 | 2 | GO:0005001 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein phosphatase activity | 2.34e-03 | 17 | 85 | 2 | GO:0019198 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion | CFH ILDR2 THBS1 PTPRF HLA-DMB SFTPD F2RL3 RC3H1 CNTN5 FER TMEM131L REG3A PCDHA4 PCDHA3 ITGAE ITGAL ITGAM YTHDF2 | 3.14e-07 | 1077 | 85 | 18 | GO:0098609 |
| GeneOntologyBiologicalProcess | detection of monosaccharide stimulus | 5.02e-05 | 3 | 85 | 2 | GO:0034287 | |
| GeneOntologyBiologicalProcess | detection of hexose stimulus | 5.02e-05 | 3 | 85 | 2 | GO:0009732 | |
| GeneOntologyBiologicalProcess | detection of carbohydrate stimulus | 5.02e-05 | 3 | 85 | 2 | GO:0009730 | |
| GeneOntologyBiologicalProcess | positive regulation of detection of glucose | 5.02e-05 | 3 | 85 | 2 | GO:2000972 | |
| GeneOntologyBiologicalProcess | regulation of detection of glucose | 5.02e-05 | 3 | 85 | 2 | GO:2000970 | |
| GeneOntologyBiologicalProcess | detection of glucose | 5.02e-05 | 3 | 85 | 2 | GO:0051594 | |
| GeneOntologyBiologicalProcess | phagocytosis | 1.38e-04 | 274 | 85 | 7 | GO:0006909 | |
| GeneOntologyBiologicalProcess | leukocyte cell-cell adhesion | 1.75e-04 | 486 | 85 | 9 | GO:0007159 | |
| GeneOntologyCellularComponent | multivesicular body | 6.95e-08 | 88 | 85 | 7 | GO:0005771 | |
| GeneOntologyCellularComponent | multivesicular body lumen | 2.24e-06 | 7 | 85 | 3 | GO:0097486 | |
| GeneOntologyCellularComponent | late endosome lumen | 1.05e-05 | 11 | 85 | 3 | GO:0031906 | |
| GeneOntologyCellularComponent | late endosome | 1.20e-05 | 348 | 85 | 9 | GO:0005770 | |
| GeneOntologyCellularComponent | voltage-gated calcium channel complex | 3.65e-05 | 46 | 85 | 4 | GO:0005891 | |
| GeneOntologyCellularComponent | side of membrane | CFH THBS1 PRSS8 CNTN5 CD109 FER SCNN1A FES ITGAE ITGAL ITGAM SPRN | 2.12e-04 | 875 | 85 | 12 | GO:0098552 |
| GeneOntologyCellularComponent | calcium channel complex | 2.24e-04 | 73 | 85 | 4 | GO:0034704 | |
| GeneOntologyCellularComponent | presynaptic active zone membrane | 2.89e-04 | 78 | 85 | 4 | GO:0048787 | |
| GeneOntologyCellularComponent | integrin complex | 2.96e-04 | 32 | 85 | 3 | GO:0008305 | |
| GeneOntologyCellularComponent | cation channel complex | 3.95e-04 | 235 | 85 | 6 | GO:0034703 | |
| GeneOntologyCellularComponent | GABA-ergic synapse | 5.53e-04 | 164 | 85 | 5 | GO:0098982 | |
| GeneOntologyCellularComponent | endosome lumen | 7.12e-04 | 43 | 85 | 3 | GO:0031904 | |
| GeneOntologyCellularComponent | endosome | PGA4 SFTPA2 PTPRF HLA-DMB SFTPD PACSIN1 APBB2 WDR81 SFTPA1 GRIN2B PGA5 PGA3 PLD4 | 8.32e-04 | 1167 | 85 | 13 | GO:0005768 |
| GeneOntologyCellularComponent | monoatomic ion channel complex | 8.80e-04 | 378 | 85 | 7 | GO:0034702 | |
| GeneOntologyCellularComponent | plasma membrane protein complex | CACNA2D1 HLA-DMB CACNA2D2 CACNA1I GRIN2B ITGAE ITGAL ITGAM CATSPERG KCNH5 | 1.30e-03 | 785 | 85 | 10 | GO:0098797 |
| GeneOntologyCellularComponent | transmembrane transporter complex | CACNA2D1 CACNA2D2 SCNN1A COX7A1 CACNA1I GRIN2B CATSPERG KCNH5 | 1.30e-03 | 523 | 85 | 8 | GO:1902495 |
| GeneOntologyCellularComponent | secretory vesicle | CACNA2D1 THBS1 SFTPA2 CD109 SCNN1A REG3G SFTPA1 REG3A CPA3 GRIN2B ITGAL ITGAM DOC2B | 1.51e-03 | 1246 | 85 | 13 | GO:0099503 |
| GeneOntologyCellularComponent | transporter complex | CACNA2D1 CACNA2D2 SCNN1A COX7A1 CACNA1I GRIN2B CATSPERG KCNH5 | 1.78e-03 | 550 | 85 | 8 | GO:1990351 |
| GeneOntologyCellularComponent | protein complex involved in cell adhesion | 1.79e-03 | 59 | 85 | 3 | GO:0098636 | |
| GeneOntologyCellularComponent | synaptic membrane | 2.55e-03 | 583 | 85 | 8 | GO:0097060 | |
| GeneOntologyCellularComponent | presynaptic active zone | 2.63e-03 | 141 | 85 | 4 | GO:0048786 | |
| GeneOntologyCellularComponent | secretory granule | CACNA2D1 THBS1 SFTPA2 CD109 SCNN1A REG3G SFTPA1 REG3A CPA3 ITGAL ITGAM | 2.64e-03 | 1014 | 85 | 11 | GO:0030141 |
| GeneOntologyCellularComponent | lamellar body | 3.26e-03 | 21 | 85 | 2 | GO:0042599 | |
| GeneOntologyCellularComponent | postsynaptic density membrane | 3.87e-03 | 157 | 85 | 4 | GO:0098839 | |
| MousePheno | increased susceptibility to Orthomyxoviridae infection | 2.66e-05 | 37 | 66 | 4 | MP:0020946 | |
| MousePheno | abnormal Bruch membrane morphology | 3.53e-05 | 14 | 66 | 3 | MP:0005239 | |
| MousePheno | abnormal cytokine level | SFTPA2 SFTPD PACSIN1 RC3H1 SFTPA1 PLCD1 KLHDC10 ITGAL USP20 PLD4 | 6.53e-05 | 470 | 66 | 10 | MP:0008713 |
| MousePheno | abnormal intercellular signaling peptide or protein level | SFTPA2 SFTPD PACSIN1 RC3H1 SFTPA1 PLCD1 KLHDC10 ITGAL USP20 PLD4 | 7.79e-05 | 480 | 66 | 10 | MP:0008835 |
| MousePheno | abnormal susceptibility to Orthomyxoviridae infection | 1.20e-04 | 54 | 66 | 4 | MP:0020945 | |
| Domain | Aspartic_peptidase_N | 1.38e-08 | 7 | 85 | 4 | IPR012848 | |
| Domain | A1_Propeptide | 1.38e-08 | 7 | 85 | 4 | PF07966 | |
| Domain | Aspartic_peptidase_A1 | 8.22e-08 | 10 | 85 | 4 | IPR001461 | |
| Domain | PEPTIDASE_A1 | 8.22e-08 | 10 | 85 | 4 | IPR033121 | |
| Domain | Asp | 8.22e-08 | 10 | 85 | 4 | PF00026 | |
| Domain | PEPTIDASE_A1 | 8.22e-08 | 10 | 85 | 4 | PS51767 | |
| Domain | - | 1.92e-07 | 12 | 85 | 4 | 2.40.70.10 | |
| Domain | ASP_PROTEASE | 1.92e-07 | 12 | 85 | 4 | PS00141 | |
| Domain | Aspartic_peptidase_AS | 2.77e-07 | 13 | 85 | 4 | IPR001969 | |
| Domain | Peptidase_aspartic_dom | 9.09e-07 | 17 | 85 | 4 | IPR021109 | |
| Domain | C-type_lectin_CS | 1.46e-06 | 43 | 85 | 5 | IPR018378 | |
| Domain | VWA | 5.52e-06 | 56 | 85 | 5 | PF00092 | |
| Domain | Integrin_alpha | 1.46e-05 | 11 | 85 | 3 | PF00357 | |
| Domain | Tyr-prot_kinase_Fes/Fps | 2.05e-05 | 2 | 85 | 2 | IPR016250 | |
| Domain | C_TYPE_LECTIN_1 | 3.19e-05 | 80 | 85 | 5 | PS00615 | |
| Domain | VWFA | 3.59e-05 | 82 | 85 | 5 | PS50234 | |
| Domain | VWA | 4.04e-05 | 84 | 85 | 5 | SM00327 | |
| Domain | Lectin_C | 4.04e-05 | 84 | 85 | 5 | PF00059 | |
| Domain | CLECT | 4.04e-05 | 84 | 85 | 5 | SM00034 | |
| Domain | C_TYPE_LECTIN_2 | 4.27e-05 | 85 | 85 | 5 | PS50041 | |
| Domain | C-type_lectin-like | 4.52e-05 | 86 | 85 | 5 | IPR001304 | |
| Domain | Integrin_alpha_C_CS | 4.88e-05 | 16 | 85 | 3 | IPR018184 | |
| Domain | Integrin_alpha-2 | 7.07e-05 | 18 | 85 | 3 | IPR013649 | |
| Domain | Integrin_alpha2 | 7.07e-05 | 18 | 85 | 3 | PF08441 | |
| Domain | Integrin_alpha | 7.07e-05 | 18 | 85 | 3 | IPR000413 | |
| Domain | INTEGRIN_ALPHA | 7.07e-05 | 18 | 85 | 3 | PS00242 | |
| Domain | - | 8.04e-05 | 97 | 85 | 5 | 3.10.100.10 | |
| Domain | Int_alpha_beta-p | 8.36e-05 | 19 | 85 | 3 | IPR013519 | |
| Domain | Int_alpha | 8.36e-05 | 19 | 85 | 3 | SM00191 | |
| Domain | C-type_lectin-like/link | 8.86e-05 | 99 | 85 | 5 | IPR016186 | |
| Domain | VWF_A | 8.86e-05 | 99 | 85 | 5 | IPR002035 | |
| Domain | VGCC_alpha2 | 1.22e-04 | 4 | 85 | 2 | PF08473 | |
| Domain | VDCC_a2/dsu | 1.22e-04 | 4 | 85 | 2 | IPR013680 | |
| Domain | CTDL_fold | 1.28e-04 | 107 | 85 | 5 | IPR016187 | |
| Domain | FCH | 1.32e-04 | 22 | 85 | 3 | PF00611 | |
| Domain | FG_GAP | 1.32e-04 | 22 | 85 | 3 | PS51470 | |
| Domain | FCH | 1.32e-04 | 22 | 85 | 3 | SM00055 | |
| Domain | FCH_dom | 1.51e-04 | 23 | 85 | 3 | IPR001060 | |
| Domain | FG-GAP | 1.72e-04 | 24 | 85 | 3 | PF01839 | |
| Domain | FG-GAP | 1.72e-04 | 24 | 85 | 3 | IPR013517 | |
| Domain | F_BAR | 1.95e-04 | 25 | 85 | 3 | IPR031160 | |
| Domain | Integrin_dom | 1.95e-04 | 25 | 85 | 3 | IPR032695 | |
| Domain | F_BAR | 1.95e-04 | 25 | 85 | 3 | PS51741 | |
| Domain | VWA_N | 2.03e-04 | 5 | 85 | 2 | IPR013608 | |
| Domain | VWA_N | 2.03e-04 | 5 | 85 | 2 | PF08399 | |
| Domain | Collagen | 6.11e-04 | 85 | 85 | 4 | IPR008160 | |
| Domain | Collagen | 6.11e-04 | 85 | 85 | 4 | PF01391 | |
| Domain | Apc4_WD40_dom | 3.69e-03 | 20 | 85 | 2 | IPR024977 | |
| Domain | ANAPC4_WD40 | 3.69e-03 | 20 | 85 | 2 | PF12894 | |
| Domain | Ig-like_fold | ILDR2 PTPRF PTPRH PTCRA HLA-DMB PLXNC1 VSTM2L CNTN5 CEACAM16 | 4.76e-03 | 706 | 85 | 9 | IPR013783 |
| Domain | G_patch | 4.87e-03 | 23 | 85 | 2 | SM00443 | |
| Domain | G_patch_dom | 4.87e-03 | 23 | 85 | 2 | IPR000467 | |
| Domain | G_PATCH | 4.87e-03 | 23 | 85 | 2 | PS50174 | |
| Domain | G-patch | 4.87e-03 | 23 | 85 | 2 | PF01585 | |
| Domain | PAS | 5.74e-03 | 25 | 85 | 2 | PF00989 | |
| Domain | PAS_fold | 5.74e-03 | 25 | 85 | 2 | IPR013767 | |
| Domain | PID | 7.17e-03 | 28 | 85 | 2 | PF00640 | |
| Pathway | REACTOME_SURFACTANT_METABOLISM | 2.52e-09 | 30 | 60 | 6 | M27566 | |
| Pathway | WP_GASTRIC_ACID_PRODUCTION | 9.57e-08 | 11 | 60 | 4 | M39726 | |
| Pathway | REACTOME_DEFECTIVE_CSF2RB_CAUSES_SMDP5 | 4.04e-06 | 8 | 60 | 3 | M27575 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_SURFACTANT_METABOLISM | 8.61e-06 | 10 | 60 | 3 | M27573 | |
| Pathway | REACTOME_SIGNAL_REGULATORY_PROTEIN_FAMILY_INTERACTIONS | 2.58e-05 | 14 | 60 | 3 | MM15011 | |
| Pathway | REACTOME_SIGNAL_REGULATORY_PROTEIN_FAMILY_INTERACTIONS | 3.95e-05 | 16 | 60 | 3 | M925 | |
| Pathway | REACTOME_REGULATION_OF_TLR_BY_ENDOGENOUS_LIGAND | 1.07e-04 | 22 | 60 | 3 | M27571 | |
| Pathway | REACTOME_REGULATION_OF_TLR_BY_ENDOGENOUS_LIGAND | 1.07e-04 | 22 | 60 | 3 | MM15284 | |
| Pathway | REACTOME_SURFACTANT_METABOLISM | 1.22e-04 | 23 | 60 | 3 | MM15279 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_ENTRY_VOLTAGE_GATED_CA2_CHANNEL | 1.58e-04 | 25 | 60 | 3 | M47948 | |
| Pathway | PID_INTEGRIN_CS_PATHWAY | 1.78e-04 | 26 | 60 | 3 | M47 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 3.03e-04 | 76 | 60 | 4 | MM14867 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 4.64e-04 | 85 | 60 | 4 | M16441 | |
| Pathway | BIOCARTA_NEUTROPHIL_PATHWAY | 4.91e-04 | 8 | 60 | 2 | MM1536 | |
| Pathway | BIOCARTA_NEUTROPHIL_PATHWAY | 4.91e-04 | 8 | 60 | 2 | M22010 | |
| Pathway | REACTOME_POST_TRANSLATIONAL_MODIFICATION_SYNTHESIS_OF_GPI_ANCHORED_PROTEINS | 6.53e-04 | 93 | 60 | 4 | M26985 | |
| Pathway | WP_COMPLEMENT_SYSTEM | 7.36e-04 | 96 | 60 | 4 | M39581 | |
| Pathway | REACTOME_POST_TRANSLATIONAL_MODIFICATION_SYNTHESIS_OF_GPI_ANCHORED_PROTEINS | 8.26e-04 | 99 | 60 | 4 | MM14624 | |
| Pathway | PID_HNF3A_PATHWAY | 8.57e-04 | 44 | 60 | 3 | M285 | |
| Pathway | BIOCARTA_MONOCYTE_PATHWAY | 9.56e-04 | 11 | 60 | 2 | MM1436 | |
| Pathway | BIOCARTA_MONOCYTE_PATHWAY | 9.56e-04 | 11 | 60 | 2 | M4956 | |
| Pubmed | Serum pepsinogen I/II ratio is correlated with albuminuria in patients with type 2 diabetes. | 3.65e-11 | 4 | 87 | 4 | 23047493 | |
| Pubmed | Pepsinogens, progastricsins, and prochymosins: structure, function, evolution, and development. | 3.65e-11 | 4 | 87 | 4 | 11915945 | |
| Pubmed | 3.65e-11 | 4 | 87 | 4 | 8322031 | ||
| Pubmed | 3.65e-11 | 4 | 87 | 4 | 12698190 | ||
| Pubmed | 1.82e-10 | 5 | 87 | 4 | 22066020 | ||
| Pubmed | ErbB4 regulates the timely progression of late fetal lung development. | 1.27e-09 | 7 | 87 | 4 | 20303366 | |
| Pubmed | 1.51e-08 | 3 | 87 | 3 | 3017318 | ||
| Pubmed | 1.51e-08 | 3 | 87 | 3 | 12015304 | ||
| Pubmed | Serum pepsinogen test for early detection of gastric cancer in a European country. | 1.51e-08 | 3 | 87 | 3 | 21989121 | |
| Pubmed | Surfactant proteins SP-A and SP-D: structure, function and receptors. | 1.51e-08 | 3 | 87 | 3 | 16213021 | |
| Pubmed | 1.51e-08 | 3 | 87 | 3 | 9855083 | ||
| Pubmed | 1.51e-08 | 3 | 87 | 3 | 9797498 | ||
| Pubmed | 1.51e-08 | 3 | 87 | 3 | 2478370 | ||
| Pubmed | Macrophage-independent fungicidal action of the pulmonary collectins. | 1.51e-08 | 3 | 87 | 3 | 12857753 | |
| Pubmed | 1.51e-08 | 3 | 87 | 3 | 3815274 | ||
| Pubmed | Pepsinogens: physiology, pharmacology pathophysiology and exercise. | 1.51e-08 | 3 | 87 | 3 | 10675278 | |
| Pubmed | 1.51e-08 | 3 | 87 | 3 | 7926498 | ||
| Pubmed | 1.51e-08 | 3 | 87 | 3 | 3780036 | ||
| Pubmed | 1.51e-08 | 3 | 87 | 3 | 9561228 | ||
| Pubmed | 1.51e-08 | 3 | 87 | 3 | 21455714 | ||
| Pubmed | 1.51e-08 | 3 | 87 | 3 | 19800305 | ||
| Pubmed | 1.51e-08 | 3 | 87 | 3 | 15588319 | ||
| Pubmed | 1.51e-08 | 3 | 87 | 3 | 2901984 | ||
| Pubmed | 1.51e-08 | 3 | 87 | 3 | 12376353 | ||
| Pubmed | Surfactant protein A and surfactant protein D in health and disease. | 1.51e-08 | 3 | 87 | 3 | 9688929 | |
| Pubmed | Assignment of human pepsinogen A locus to the q12-pter region of chromosome 11. | 1.51e-08 | 3 | 87 | 3 | 3839486 | |
| Pubmed | 1.51e-08 | 3 | 87 | 3 | 24170207 | ||
| Pubmed | 1.51e-08 | 3 | 87 | 3 | 18983439 | ||
| Pubmed | 1.51e-08 | 3 | 87 | 3 | 21601013 | ||
| Pubmed | 1.51e-08 | 3 | 87 | 3 | 3467902 | ||
| Pubmed | 1.51e-08 | 3 | 87 | 3 | 4586732 | ||
| Pubmed | Surfactant-associated protein A provides critical immunoprotection in neonatal mice. | 1.51e-08 | 3 | 87 | 3 | 17967856 | |
| Pubmed | Eosinophil-associated lung diseases. A cry for surfactant proteins A and D help? | 1.51e-08 | 3 | 87 | 3 | 24960334 | |
| Pubmed | Relationships between the human pepsinogen DNA and protein polymorphisms. | 1.51e-08 | 3 | 87 | 3 | 3014868 | |
| Pubmed | Genomic structure and evolution of the human pepsinogen A multigene family. | 1.51e-08 | 3 | 87 | 3 | 2892778 | |
| Pubmed | 1.51e-08 | 3 | 87 | 3 | 24383519 | ||
| Pubmed | 1.51e-08 | 3 | 87 | 3 | 1455184 | ||
| Pubmed | Hypomethylation and expression of pepsinogen A genes in the fundic mucosa of human stomach. | 1.51e-08 | 3 | 87 | 3 | 2831884 | |
| Pubmed | 1.51e-08 | 3 | 87 | 3 | 18996902 | ||
| Pubmed | The ratio of pepsinogen A to pepsinogen C: a sensitive test for atrophic gastritis. | 1.51e-08 | 3 | 87 | 3 | 2799289 | |
| Pubmed | 1.51e-08 | 3 | 87 | 3 | 19872561 | ||
| Pubmed | 1.51e-08 | 3 | 87 | 3 | 26421960 | ||
| Pubmed | 1.51e-08 | 3 | 87 | 3 | 26849628 | ||
| Pubmed | Human pepsinogen A (PGA): an informative gene complex located at 11q13. | 1.51e-08 | 3 | 87 | 3 | 1968039 | |
| Pubmed | 1.51e-08 | 3 | 87 | 3 | 2515193 | ||
| Pubmed | 1.51e-08 | 3 | 87 | 3 | 2032552 | ||
| Pubmed | 1.51e-08 | 3 | 87 | 3 | 8053437 | ||
| Pubmed | 1.51e-08 | 3 | 87 | 3 | 19155216 | ||
| Pubmed | 1.51e-08 | 3 | 87 | 3 | 1812762 | ||
| Pubmed | 1.51e-08 | 3 | 87 | 3 | 7923573 | ||
| Pubmed | Family and population studies on the human pepsinogen A multigene family. | 1.51e-08 | 3 | 87 | 3 | 2566575 | |
| Pubmed | 1.51e-08 | 3 | 87 | 3 | 9061458 | ||
| Pubmed | Ratio between serum IL-8 and pepsinogen A/C: a marker for atrophic body gastritis. | 1.51e-08 | 3 | 87 | 3 | 12588289 | |
| Pubmed | 1.51e-08 | 3 | 87 | 3 | 10047533 | ||
| Pubmed | Immunoblot technique to visualise serum pepsinogen A isozymogen patterns. | 1.51e-08 | 3 | 87 | 3 | 2229438 | |
| Pubmed | 1.51e-08 | 3 | 87 | 3 | 25314140 | ||
| Pubmed | Validation of the pepsinogen test method for gastric cancer screening using a follow-up study. | 1.51e-08 | 3 | 87 | 3 | 19890696 | |
| Pubmed | Role of surfactant proteins A and D in sepsis-induced acute kidney injury. | 1.51e-08 | 3 | 87 | 3 | 25255378 | |
| Pubmed | Pulmonary collectins modulate strain-specific influenza a virus infection and host responses. | 1.51e-08 | 3 | 87 | 3 | 15280465 | |
| Pubmed | Gastric cancer detection using gastric juice pepsinogen and melanoma-associated gene RNA. | 1.51e-08 | 3 | 87 | 3 | 23897256 | |
| Pubmed | An aspartic proteinase expressed in the yolk sac and neonatal stomach of the mouse. | 1.51e-08 | 3 | 87 | 3 | 11566730 | |
| Pubmed | 1.51e-08 | 3 | 87 | 3 | 8725251 | ||
| Pubmed | The effect of acute and chronic protein loading on urinary pepsinogen A excretion. | 1.51e-08 | 3 | 87 | 3 | 1956484 | |
| Pubmed | Change of surfactant protein D and A after renal ischemia reperfusion injury. | 1.51e-08 | 3 | 87 | 3 | 31877195 | |
| Pubmed | 1.51e-08 | 3 | 87 | 3 | 8540382 | ||
| Pubmed | Diagnostic value of serum pepsinogen C in patients with raised serum concentrations of pepsinogen A. | 1.51e-08 | 3 | 87 | 3 | 8244094 | |
| Pubmed | 1.51e-08 | 3 | 87 | 3 | 21407214 | ||
| Pubmed | 1.51e-08 | 3 | 87 | 3 | 22992016 | ||
| Pubmed | 1.51e-08 | 3 | 87 | 3 | 38375572 | ||
| Pubmed | The role of serum pepsinogen in the detection of gastric cancer. | 1.51e-08 | 3 | 87 | 3 | 20981206 | |
| Pubmed | 1.51e-08 | 3 | 87 | 3 | 6774973 | ||
| Pubmed | Gastric chief cell-specific transcription of the pepsinogen A gene. | 1.51e-08 | 3 | 87 | 3 | 8504820 | |
| Pubmed | Detection of pepsinogen in the neonatal lung and stomach by immunohistochemistry. | 1.51e-08 | 3 | 87 | 3 | 21970995 | |
| Pubmed | 1.51e-08 | 3 | 87 | 3 | 20413160 | ||
| Pubmed | 1.51e-08 | 3 | 87 | 3 | 6300126 | ||
| Pubmed | Pepsinogen I/II ratio is related to glucose, triacylglycerol, and uric acid levels. | 1.51e-08 | 3 | 87 | 3 | 22304859 | |
| Pubmed | 1.51e-08 | 3 | 87 | 3 | 24004680 | ||
| Pubmed | 1.51e-08 | 3 | 87 | 3 | 8038355 | ||
| Pubmed | 1.51e-08 | 3 | 87 | 3 | 15905537 | ||
| Pubmed | 1.51e-08 | 3 | 87 | 3 | 20428942 | ||
| Pubmed | Surfactant proteins A and D enhance pulmonary clearance of Pseudomonas aeruginosa. | 1.51e-08 | 3 | 87 | 3 | 16456184 | |
| Pubmed | Human pepsinogen A isozymogen patterns in serum and gastric mucosa. | 1.51e-08 | 3 | 87 | 3 | 2227273 | |
| Pubmed | 1.51e-08 | 3 | 87 | 3 | 9525001 | ||
| Pubmed | 1.51e-08 | 3 | 87 | 3 | 7886402 | ||
| Pubmed | 1.51e-08 | 3 | 87 | 3 | 23034090 | ||
| Pubmed | 1.51e-08 | 3 | 87 | 3 | 24125879 | ||
| Pubmed | 1.51e-08 | 3 | 87 | 3 | 17379991 | ||
| Pubmed | 1.51e-08 | 3 | 87 | 3 | 8751234 | ||
| Pubmed | Enzyme-linked immunosorbent assay and radioimmunoassay of serum pepsinogen A. | 1.51e-08 | 3 | 87 | 3 | 3554488 | |
| Pubmed | 1.51e-08 | 3 | 87 | 3 | 21199913 | ||
| Pubmed | 1.51e-08 | 3 | 87 | 3 | 26511057 | ||
| Pubmed | 1.51e-08 | 3 | 87 | 3 | 21547904 | ||
| Pubmed | 1.51e-08 | 3 | 87 | 3 | 23521833 | ||
| Pubmed | 6.04e-08 | 4 | 87 | 3 | 12244199 | ||
| Pubmed | Retinal degeneration mutation in Sftpa1tm1Kor/J and Sftpd -/- targeted mice. | 6.04e-08 | 4 | 87 | 3 | 29969487 | |
| Pubmed | 6.04e-08 | 4 | 87 | 3 | 10423401 | ||
| Pubmed | 6.04e-08 | 4 | 87 | 3 | 16861641 | ||
| Pubmed | 6.04e-08 | 4 | 87 | 3 | 15145932 | ||
| Pubmed | 6.04e-08 | 4 | 87 | 3 | 26603976 | ||
| Pubmed | 6.04e-08 | 4 | 87 | 3 | 27262512 | ||
| Interaction | SFTPA1 interactions | 4.28e-06 | 8 | 87 | 3 | int:SFTPA1 | |
| Interaction | ALKAL2 interactions | 1.25e-05 | 11 | 87 | 3 | int:ALKAL2 | |
| Interaction | PLA2G5 interactions | 1.66e-05 | 12 | 87 | 3 | int:PLA2G5 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 1.95e-07 | 41 | 58 | 5 | 1298 | |
| GeneFamily | Collectins | 3.70e-06 | 10 | 58 | 3 | 491 | |
| GeneFamily | CD molecules|Integrin alpha subunits | 2.47e-05 | 18 | 58 | 3 | 1160 | |
| GeneFamily | Rho GTPase activating proteins|F-BAR domain containing | 5.30e-05 | 23 | 58 | 3 | 1288 | |
| GeneFamily | Calcium voltage-gated channel subunits | 7.73e-05 | 26 | 58 | 3 | 253 | |
| GeneFamily | Protein tyrosine phosphatases, receptor type | 2.04e-03 | 21 | 58 | 2 | 813 | |
| GeneFamily | G-patch domain containing|Minor histocompatibility antigens | 2.24e-03 | 22 | 58 | 2 | 579 | |
| GeneFamily | Zinc fingers CCCH-type | 5.62e-03 | 35 | 58 | 2 | 73 | |
| GeneFamily | Complement system|Sushi domain containing | 5.94e-03 | 36 | 58 | 2 | 492 | |
| GeneFamily | Phospholipases | 8.02e-03 | 42 | 58 | 2 | 467 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 8.53e-03 | 394 | 58 | 5 | 471 | |
| Coexpression | NABA_ECM_AFFILIATED | 9.12e-07 | 158 | 86 | 7 | MM17063 | |
| Coexpression | TRAVAGLINI_LUNG_SIGNALING_ALVEOLAR_EPITHELIAL_TYPE_2_CELL | 3.71e-06 | 71 | 86 | 5 | M41661 | |
| Coexpression | NABA_ECM_AFFILIATED | 2.09e-05 | 170 | 86 | 6 | M5880 | |
| Coexpression | DESCARTES_FETAL_ADRENAL_MEGAKARYOCYTES | 3.75e-05 | 114 | 86 | 5 | M40146 | |
| Coexpression | GSE6259_BCELL_VS_CD8_TCELL_UP | 4.25e-05 | 193 | 86 | 6 | M6735 | |
| Coexpression | GSE9316_CD4_TCELL_BALBC_VS_TH17_ENRI_CD4_TCELL_SKG_PMA_IONO_STIM_FR4NEG_DN | 5.18e-05 | 200 | 86 | 6 | M6894 | |
| Coexpression | GSE12392_IFNAR_KO_VS_IFNB_KO_CD8_NEG_SPLEEN_DC_DN | 5.18e-05 | 200 | 86 | 6 | M7136 | |
| Coexpression | GSE7831_UNSTIM_VS_INFLUENZA_STIM_PDC_4H_DN | 5.18e-05 | 200 | 86 | 6 | M6956 | |
| Coexpression | TRAVAGLINI_LUNG_ALVEOLAR_EPITHELIAL_TYPE_2_CELL | 8.68e-05 | 136 | 86 | 5 | M41660 | |
| CoexpressionAtlas | alpha beta T cells, preT.DN3A.Th, Lin-/lo CD25hi CD44- CD28-, Thymus, avg-3 | 1.64e-06 | 89 | 86 | 6 | GSM791146_100 | |
| ToppCell | 343B-Epithelial_cells|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.97e-10 | 198 | 87 | 9 | 0756a5d01572343abce77e7584b816c2c2e9d9c7 | |
| ToppCell | (7)_Epithelial-D_(AT2)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 3.83e-09 | 190 | 87 | 8 | 832d6d3ad14665e50623afe1b8586ccae1a97de5 | |
| ToppCell | 367C-Epithelial_cells|367C / Donor, Lineage, Cell class and subclass (all cells) | 3.99e-09 | 191 | 87 | 8 | d31975fc33779b0b3ff1a50d7c64fec8d08be4d4 | |
| ToppCell | (7)_Epithelial_cells|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 4.51e-09 | 194 | 87 | 8 | 413e8b9f1e15be363a7f4a8f727af3eeb9e9a928 | |
| ToppCell | AT2|World / shred by cell class for parenchyma | 4.51e-09 | 194 | 87 | 8 | e773f5ef3abce7113a6b7cc7cbe68de873d4a17f | |
| ToppCell | 356C-Epithelial_cells|356C / Donor, Lineage, Cell class and subclass (all cells) | 4.70e-09 | 195 | 87 | 8 | d913d0a6c4797d9a873ddea6f340c3f152da1cf3 | |
| ToppCell | AT2_cells-Donor_06|World / lung cells shred on cell class, cell subclass, sample id | 4.70e-09 | 195 | 87 | 8 | b0cea3f4e59635913d243612f2e8cf4c7b34e726 | |
| ToppCell | 343B|World / Donor, Lineage, Cell class and subclass (all cells) | 4.70e-09 | 195 | 87 | 8 | 2290911fde6efacfa38b985a2541322968bee42d | |
| ToppCell | normal_Lung-Epithelial_cells|normal_Lung / Location, Cell class and cell subclass | 4.70e-09 | 195 | 87 | 8 | 7c90d887afde5c4d63352b5171be9987e2dfca58 | |
| ToppCell | (7)_Epithelial-B_(AT2)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 4.89e-09 | 196 | 87 | 8 | 345d4cc062b43bca9d506fbf23363469a9ba496f | |
| ToppCell | Parenchymal-10x3prime_v2-Epithelial-Epi_alveolar|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 5.51e-09 | 199 | 87 | 8 | 7ebd89dff457f57a549eecee288c7a4b515b4018 | |
| ToppCell | Epithelial_cells|World / lung cells shred on cell class, cell subclass, sample id | 5.51e-09 | 199 | 87 | 8 | bbe69e44b7970f57628365ae771790f2b13d0cae | |
| ToppCell | distal-1-Epithelial|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.51e-09 | 199 | 87 | 8 | 9086dbb60863c3da2cc5d0a310f28596a01c52ca | |
| ToppCell | proximal|World / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.73e-09 | 200 | 87 | 8 | 33f05ed458c889bf241580f513ce66797007248c | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.73e-09 | 200 | 87 | 8 | 21d9cf3cd3696ad6b745c7c036798f04b6ce5160 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.73e-09 | 200 | 87 | 8 | c2bde99b3bc7a8740441c1a0c1394892b940b857 | |
| ToppCell | cellseq-Epithelial|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.73e-09 | 200 | 87 | 8 | e4204c4b864346f47d76b0f0faae96f04fed5082 | |
| ToppCell | distal-Epithelial|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.73e-09 | 200 | 87 | 8 | 0a97080f694738bb882787cee21b91a4d5757b7a | |
| ToppCell | proximal-Epithelial|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.73e-09 | 200 | 87 | 8 | 3790dd13c4ff471e716e5a2950f196e3c386dbb1 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.73e-09 | 200 | 87 | 8 | 3ff9abd5e07780a59d5571da906fa15f00a1d5c2 | |
| ToppCell | proximal-3-Epithelial|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.73e-09 | 200 | 87 | 8 | 08858bb20630849ffb2192631e23466c242a1078 | |
| ToppCell | Biopsy_Other_PF-Epithelial|Biopsy_Other_PF / Sample group, Lineage and Cell type | 5.73e-09 | 200 | 87 | 8 | 1ef4d5ae698fa721e0f510bf0d918bd8d3b00591 | |
| ToppCell | Biopsy_Control_(H.)-Epithelial|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 5.73e-09 | 200 | 87 | 8 | 0afd93c4fdcc118bcfa77f3b59f6ff7d9293a7a4 | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.73e-09 | 200 | 87 | 8 | 33658d5d09e2eaff60f4dd88837d4252328eab63 | |
| ToppCell | Parenchyma_COVID-19-Epithelial-TX|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 5.73e-09 | 200 | 87 | 8 | d5426cd318a8f90c0bd8f9804351ab230fafc995 | |
| ToppCell | Parenchymal-10x3prime_v2-Epithelial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 5.73e-09 | 200 | 87 | 8 | 16828c6a2be66bbbd805453325d6da719f2dea1b | |
| ToppCell | Parenchymal-10x5prime-Epithelial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.73e-09 | 200 | 87 | 8 | 4e5b6cb014d9bcb58e13c7511c86c43e27c496e4 | |
| ToppCell | Parenchyma_Control_(B.)-Epithelial-TX|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 5.73e-09 | 200 | 87 | 8 | 9970e9bde6aa2ff3aef60dcb065ff15b7463e147 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-D_(AT2)|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.90e-08 | 160 | 87 | 7 | ac5d573c135d66d6adddd42dfddd9d3e01532172 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-D_(AT2)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.90e-08 | 160 | 87 | 7 | b81d218c20fe37921cf3c6c7db2da3bfd367230a | |
| ToppCell | 368C-Epithelial_cells-Epithelial-A_(AT2)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 3.44e-08 | 164 | 87 | 7 | 85f53d184fa70e3eb1af655807f32b17ddbfb304 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-A_(AT2)|368C / Donor, Lineage, Cell class and subclass (all cells) | 3.44e-08 | 164 | 87 | 7 | 144ba070a1ede71684224cc6d4ead3b7e6a7b4c6 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-B_(AT2)|367C / Donor, Lineage, Cell class and subclass (all cells) | 4.06e-08 | 168 | 87 | 7 | e20e1936573fdde78426d7a4eb45c458d5c4dbb4 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-B_(AT2)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 4.06e-08 | 168 | 87 | 7 | 16b517e3159ad6e6d25fd48f7d5f46e77b2b318d | |
| ToppCell | 367C-Epithelial_cells-Epithelial-A_(AT2)|367C / Donor, Lineage, Cell class and subclass (all cells) | 7.57e-08 | 184 | 87 | 7 | 0ba243cbf69b4fe6ae100a7f0314317bec38026c | |
| ToppCell | COVID-19-Epithelial_cells-AT2|COVID-19 / group, cell type (main and fine annotations) | 7.57e-08 | 184 | 87 | 7 | 369b82f793deab672204558ae4e112cfa5aa9ccc | |
| ToppCell | 367C-Epithelial_cells-Epithelial-A_(AT2)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 7.57e-08 | 184 | 87 | 7 | 2a8338e94937686a148b5433515700ca0f674058 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-E_(AT2)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 8.45e-08 | 187 | 87 | 7 | 11670a85db87cbb3e78022a589632173604b0940 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-E_(AT2)|367C / Donor, Lineage, Cell class and subclass (all cells) | 8.45e-08 | 187 | 87 | 7 | 0277d4e54bd4d48f30241c2951a569209423fee8 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-E_(AT2)|368C / Donor, Lineage, Cell class and subclass (all cells) | 9.09e-08 | 189 | 87 | 7 | 6f2322d017b74a1757c81d6e06f50ead8c3dd0cc | |
| ToppCell | Adult|World / Lineage, Cell type, age group and donor | 9.09e-08 | 189 | 87 | 7 | 5cd285bfad973125d46d704fec18b21266a63379 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-E_(AT2)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 9.09e-08 | 189 | 87 | 7 | 926b5fa3064b501a57ba78583e8af33532add455 | |
| ToppCell | COVID-19-lung-AT2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 9.42e-08 | 190 | 87 | 7 | 27a1a86620fe9b5ee930d388b32352206485e6d0 | |
| ToppCell | 368C-Epithelial_cells|368C / Donor, Lineage, Cell class and subclass (all cells) | 9.42e-08 | 190 | 87 | 7 | 459811e88d3001816c2d89034e0921c24918c17f | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.1.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.76e-08 | 191 | 87 | 7 | 6cb2c107bc674aa173b4009f320a1687a76f3979 | |
| ToppCell | (7)_Epithelial-E_(AT2)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 9.76e-08 | 191 | 87 | 7 | 0fc8d109d5c50957ceef5b8b8b818b0c598b1bbe | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D122|Adult / Lineage, Cell type, age group and donor | 1.01e-07 | 192 | 87 | 7 | 06013a07e3a873b1d1c0451643c528593ac32a9c | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.4.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.05e-07 | 193 | 87 | 7 | 043dd0fc2f93e0bd1ca34ac3e196622b3e91df0f | |
| ToppCell | cellseq-Epithelial-Epithelial_Alveolar-AT2-AT2|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.12e-07 | 195 | 87 | 7 | 6867f9c56ea27a17c8c4099aae0d79903c3748a5 | |
| ToppCell | cellseq-Epithelial-Epithelial_Alveolar-AT2|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.12e-07 | 195 | 87 | 7 | 955a0a7244cd7eaf006a39e1bd03333baf6f30a4 | |
| ToppCell | nucseq-Epithelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.12e-07 | 195 | 87 | 7 | 9406866f99555198a9be311fbd65751b70f35446 | |
| ToppCell | Control-Epithelial|Control / Disease state, Lineage and Cell class | 1.12e-07 | 195 | 87 | 7 | 1798c3b89b1b5ff4f5777d2b9f52dc81cdad28fa | |
| ToppCell | 356C-Epithelial_cells-Epithelial-A_(AT2)|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.16e-07 | 196 | 87 | 7 | 93a5d9b8bcff7d07596ef1f4f2b74f043835fc69 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-A_(AT2)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.16e-07 | 196 | 87 | 7 | 4715f19f844e7244fc4bc446cba7c8088c600fc3 | |
| ToppCell | LAM-Epithelial|LAM / Condition, Lineage and Cell class | 1.21e-07 | 197 | 87 | 7 | e5cf07061f6d9db7f12ac17209b267373fa2270b | |
| ToppCell | 343B-Epithelial_cells-Epithelial-B_(AT2)|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.21e-07 | 197 | 87 | 7 | f3ca63c7902d7530a29a85eb54f69b303031d150 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-B_(AT2)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.21e-07 | 197 | 87 | 7 | f98720cab066579fdac3ba24fb6fe4c5759dae4e | |
| ToppCell | AT2_cells|World / lung cells shred on cell class, cell subclass, sample id | 1.25e-07 | 198 | 87 | 7 | 92c569c3b8a9fca2d4682cbf77ee8149bcc0a80a | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-Transitional_AT2|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.29e-07 | 199 | 87 | 7 | b44d74895846e2ac144438b73e0ca91e3949c16c | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-Transitional_AT2-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.29e-07 | 199 | 87 | 7 | 4b374a5de82b4614d3d8a00202ea6cb8f1fd8104 | |
| ToppCell | Biopsy_IPF-Epithelial-Transitional_AT2|Biopsy_IPF / Sample group, Lineage and Cell type | 1.29e-07 | 199 | 87 | 7 | 83ff8b7e472d1212324c05cc719b746d19e5e23b | |
| ToppCell | Parenchyma_Control_(B.)-Epithelial-TX-Transitional_AT2|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 1.29e-07 | 199 | 87 | 7 | 9e8231c9007d8d963805a4c99e0905538ceb9b60 | |
| ToppCell | ASK428-Epithelial|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.29e-07 | 199 | 87 | 7 | ba2aaaeb4d9b448a6b9660b152fcac1a0e3fcfe7 | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_alveolar|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.29e-07 | 199 | 87 | 7 | a38a981cffa61c8444a980916de7414e689a1b63 | |
| ToppCell | Parenchymal-10x3prime_v2-Epithelial-Epi_alveolar-AT2|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.29e-07 | 199 | 87 | 7 | fa5ddba3ac1ebe712cd4cdc3f20339f7c715d039 | |
| ToppCell | Biopsy_Control_(H.)-Epithelial-AT2|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 1.29e-07 | 199 | 87 | 7 | 5323d49d3be980605b3e609b7f03bddba6e50e8a | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.29e-07 | 199 | 87 | 7 | e459d5aa63c83f960562be33cea8182b0556eabf | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Type_2_alveolar|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.29e-07 | 199 | 87 | 7 | e28ace2ca680c6154398e17110aa1838dd7a5548 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Neuron-Neuron|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.34e-07 | 200 | 87 | 7 | 2f481e2fd248c02a5aa2e0248c16808df142fed2 | |
| ToppCell | Bronchial-10x5prime-Epithelial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.34e-07 | 200 | 87 | 7 | d3ee5f79513e2ac02ad3329b59e6290d457c44d2 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-AT2-2-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.34e-07 | 200 | 87 | 7 | 3c251ad03fbbdae91dfd9037880ba43adbb03807 | |
| ToppCell | Parenchyma_COVID-19-Epithelial-TX-AT2-1|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 1.34e-07 | 200 | 87 | 7 | cf1991853e10c562edae9a0d71a209f35b07db80 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Neuron-Neuron-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.34e-07 | 200 | 87 | 7 | bd4b9f6b37f4a3c960c4149cf0cfd2caf3327d2d | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-AT2-2|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.34e-07 | 200 | 87 | 7 | c905451425d1c24773bb0ca69bcf0309b277d2f1 | |
| ToppCell | Parenchyma_COVID-19-Epithelial-TX-Transitional_AT2|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 1.34e-07 | 200 | 87 | 7 | dfa897ef5ce4744c77b6e5ee5a0d6d83229d1691 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-AT2-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.34e-07 | 200 | 87 | 7 | 65c83a3f6ee2a10bcb5b95076696232c6373a7b4 | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_alveolar-AT2|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.34e-07 | 200 | 87 | 7 | 23088edc62bf7d4db890937bfd7925dc316fcc76 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-AT2-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.34e-07 | 200 | 87 | 7 | 40e969883bc302e8fbc6b6ab9814529dc1472902 | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-Transitional_AT2-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.34e-07 | 200 | 87 | 7 | 8d1c78dd829cbc290820d5118f24ff7f828a8622 | |
| ToppCell | Parenchyma_Control_(B.)-Epithelial-TX-AT2-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 1.34e-07 | 200 | 87 | 7 | ad9cdc82a647d379abc713a56db0e11bb6494106 | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-AT2-2|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.34e-07 | 200 | 87 | 7 | acc771a902cf2f060c3eb9aedb72a256f5778a6c | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_alveolar|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.34e-07 | 200 | 87 | 7 | b2d61bc3afac0d78aa30082760da5b1a15d1fad2 | |
| ToppCell | Parenchyma_COVID-19-Epithelial-TX-AT2-2|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 1.34e-07 | 200 | 87 | 7 | ceb613ac6cdf0e3e6bb3f04d89034e18a524cefb | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_alveolar-AT2|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.34e-07 | 200 | 87 | 7 | b535323e18d9fb0dde1e0026df142c831e48c29f | |
| ToppCell | Parenchyma_Control_(B.)-Epithelial-TX-AT2-2|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 1.34e-07 | 200 | 87 | 7 | 35c05cae30cd6b323d2662f1396ddeab08bc75fc | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Neuron|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.34e-07 | 200 | 87 | 7 | dc674124475edf83908b51a4e1454bc2dc4f06fa | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-AT2-1-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.34e-07 | 200 | 87 | 7 | 7618ae284625c5c121bcc00eb9f07e5b1e3adf23 | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-AT2-2-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.34e-07 | 200 | 87 | 7 | eb44d1f80ecaac3a022cd04ab16dc36151e45488 | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-Transitional_AT2|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.34e-07 | 200 | 87 | 7 | 992bd6b1feac2afded6eb927ac95ddf5cfef961c | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-AT2-1|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.34e-07 | 200 | 87 | 7 | 23b319bf7e5ae03e5baa777c951da9bfc97cca8c | |
| ToppCell | distal-3-Epithelial|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.34e-07 | 200 | 87 | 7 | 698c09d383b652178e4e150151139031b6e891bc | |
| ToppCell | ASK440-Epithelial|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.34e-07 | 200 | 87 | 7 | cb617e2a0ca82b470b473b8d5906bc8879c85718 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c09-GZMK-FOS_l|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.06e-07 | 129 | 87 | 6 | a60935ff9c5a841899ccfe90531533ba4c546df3 | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Hematologic-fibroblast|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-06 | 169 | 87 | 6 | 15a9183c838cc6384d7f5dfeae3d30602964c9b3 | |
| ToppCell | Endothelial-B-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 1.01e-06 | 169 | 87 | 6 | 8889c9e8af1ab0b093d57b69abd80b59b3461be9 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.12e-06 | 172 | 87 | 6 | a9e65201ad9ab4f64251aba2c0bb3d8f9e0193b6 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.12e-06 | 172 | 87 | 6 | 26006967d0c82f7bd9b36a18e97a1b93e856aa67 | |
| ToppCell | AT2_cells-Donor_05|World / lung cells shred on cell class, cell subclass, sample id | 1.99e-06 | 190 | 87 | 6 | 46dfab02c1b4a403b7efc871707b6a189eefd4c4 | |
| ToppCell | COVID-19-lung-AT2|lung / Disease (COVID-19 only), tissue and cell type | 2.05e-06 | 191 | 87 | 6 | 276455a64c2c3503d5048615762eb2ee37f0ac70 | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_2|World / Lineage, Cell type, age group and donor | 2.12e-06 | 192 | 87 | 6 | 58c3737be7acce39fd2b91d70d6d7b2bbaa4f710 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 3.55e-06 | 50 | 51 | 5 | GAVISH_3CA_MALIGNANT_METAPROGRAM_31_ALVEOLAR | |
| Computational | Genes in the cancer module 412. | 2.78e-05 | 13 | 51 | 3 | MODULE_412 | |
| Computational | Genes in the cancer module 275. | 5.40e-05 | 16 | 51 | 3 | MODULE_275 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 8.81e-05 | 50 | 51 | 4 | GAVISH_3CA_METAPROGRAM_EPITHELIAL_ALVEOLAR | |
| Drug | Landel | 4.30e-06 | 9 | 86 | 3 | CID000163838 | |
| Drug | caffeine | CACNA2D1 AHRR DRD3 CACNA2D2 COX7A1 CACNA1I CYP4F12 PLCD1 GRIN2B GRM7 GBA2 | 8.63e-06 | 562 | 86 | 11 | CID000002519 |
| Drug | (-)-Adenosine 3',5'-cyclic monophosphate [60-92-4]; Up 200; 12.2uM; HL60; HT_HG-U133A | 9.52e-06 | 196 | 86 | 7 | 2969_UP | |
| Disease | newborn respiratory distress syndrome (biomarker_via_orthology) | 4.27e-07 | 6 | 83 | 3 | DOID:12716 (biomarker_via_orthology) | |
| Disease | newborn respiratory distress syndrome (is_implicated_in) | 7.45e-07 | 7 | 83 | 3 | DOID:12716 (is_implicated_in) | |
| Disease | bacterial pneumonia (biomarker_via_orthology) | 7.64e-06 | 14 | 83 | 3 | DOID:874 (biomarker_via_orthology) | |
| Disease | tumor necrosis factor receptor superfamily member 6B measurement | 2.34e-05 | 3 | 83 | 2 | EFO_0020815 | |
| Disease | level of leukocyte immunoglobulin-like receptor subfamily B member 4 in blood serum | 7.77e-05 | 5 | 83 | 2 | OBA_2042200 | |
| Disease | acute pancreatitis (implicated_via_orthology) | 7.77e-05 | 5 | 83 | 2 | DOID:2913 (implicated_via_orthology) | |
| Disease | level of prosaposin in blood serum | 7.77e-05 | 5 | 83 | 2 | OBA_2044552 | |
| Disease | mediator of RNA polymerase II transcription subunit 1 measurement | 1.16e-04 | 6 | 83 | 2 | EFO_0008228 | |
| Disease | pulmonary alveolar proteinosis (is_marker_for) | 1.16e-04 | 6 | 83 | 2 | DOID:12120 (is_marker_for) | |
| Disease | lung disease (biomarker_via_orthology) | 1.32e-04 | 35 | 83 | 3 | DOID:850 (biomarker_via_orthology) | |
| Disease | unipolar depression | CFH CACNA2D1 PLXNC1 FAM78B CNTN5 FER INTS9 PCDHA4 PCDHA3 GRIN2B GRM7 KCNH5 | 1.37e-04 | 1206 | 83 | 12 | EFO_0003761 |
| Disease | obsolete_interleukin-1 alpha measurement | 1.63e-04 | 7 | 83 | 2 | EFO_0802653 | |
| Disease | sciatic neuropathy (biomarker_via_orthology) | 1.79e-04 | 99 | 83 | 4 | DOID:11446 (biomarker_via_orthology) | |
| Disease | placental insufficiency (biomarker_via_orthology) | 2.16e-04 | 8 | 83 | 2 | DOID:3891 (biomarker_via_orthology) | |
| Disease | leukocyte immunoglobulin-like receptor subfamily B member 4 measurement | 2.16e-04 | 8 | 83 | 2 | EFO_0801768 | |
| Disease | diabetic retinopathy (biomarker_via_orthology) | 2.80e-04 | 45 | 83 | 3 | DOID:8947 (biomarker_via_orthology) | |
| Disease | pneumonia (implicated_via_orthology) | 3.47e-04 | 10 | 83 | 2 | DOID:552 (implicated_via_orthology) | |
| Disease | respiratory syncytial virus infectious disease (is_implicated_in) | 3.47e-04 | 10 | 83 | 2 | DOID:1273 (is_implicated_in) | |
| Disease | complement C1q tumor necrosis factor-related protein 1 measurement | 5.07e-04 | 12 | 83 | 2 | EFO_0801493 | |
| Disease | granulins measurement | 5.07e-04 | 12 | 83 | 2 | EFO_0008141 | |
| Disease | bronchopulmonary dysplasia (is_implicated_in) | 5.98e-04 | 13 | 83 | 2 | DOID:11650 (is_implicated_in) | |
| Disease | asthma (biomarker_via_orthology) | 6.23e-04 | 59 | 83 | 3 | DOID:2841 (biomarker_via_orthology) | |
| Disease | Hamman-Rich syndrome | 6.96e-04 | 14 | 83 | 2 | C0085786 | |
| Disease | 1-methylurate measurement | 6.96e-04 | 14 | 83 | 2 | EFO_0021173 | |
| Disease | type 2 diabetes mellitus (biomarker_via_orthology) | 8.01e-04 | 147 | 83 | 4 | DOID:9352 (biomarker_via_orthology) | |
| Disease | obesity (biomarker_via_orthology) | 8.01e-04 | 147 | 83 | 4 | DOID:9970 (biomarker_via_orthology) | |
| Disease | lupus nephritis (is_implicated_in) | 1.16e-03 | 18 | 83 | 2 | DOID:0080162 (is_implicated_in) | |
| Disease | sinusitis (is_marker_for) | 1.16e-03 | 18 | 83 | 2 | DOID:0050127 (is_marker_for) | |
| Disease | respiratory syncytial virus infectious disease (is_marker_for) | 1.16e-03 | 18 | 83 | 2 | DOID:1273 (is_marker_for) | |
| Disease | epilepsy (implicated_via_orthology) | 1.17e-03 | 163 | 83 | 4 | DOID:1826 (implicated_via_orthology) | |
| Disease | schizophrenia (is_implicated_in) | 1.40e-03 | 78 | 83 | 3 | DOID:5419 (is_implicated_in) | |
| Disease | Familial Idiopathic Pulmonary Fibrosis | 1.44e-03 | 20 | 83 | 2 | C4721952 | |
| Disease | feeling miserable measurement | 1.45e-03 | 79 | 83 | 3 | EFO_0009598 | |
| Disease | cardiovascular system disease (is_implicated_in) | 1.59e-03 | 21 | 83 | 2 | DOID:1287 (is_implicated_in) | |
| Disease | Idiopathic Pulmonary Fibrosis | 1.59e-03 | 21 | 83 | 2 | C1800706 | |
| Disease | Allodynia | 1.74e-03 | 84 | 83 | 3 | C0458247 | |
| Disease | Mechanical Allodynia | 1.74e-03 | 84 | 83 | 3 | C2936719 | |
| Disease | Hyperalgesia, Secondary | 1.74e-03 | 84 | 83 | 3 | C0751212 | |
| Disease | Hyperalgesia, Primary | 1.74e-03 | 84 | 83 | 3 | C0751211 | |
| Disease | Hyperalgesia, Thermal | 1.74e-03 | 84 | 83 | 3 | C0751214 | |
| Disease | Tactile Allodynia | 1.74e-03 | 84 | 83 | 3 | C0751213 | |
| Disease | Hyperalgesia | 1.74e-03 | 84 | 83 | 3 | C0020429 | |
| Disease | lung disease (is_implicated_in) | 1.74e-03 | 22 | 83 | 2 | DOID:850 (is_implicated_in) | |
| Disease | lung disease (is_marker_for) | 1.74e-03 | 22 | 83 | 2 | DOID:850 (is_marker_for) | |
| Disease | coffee consumption measurement | 1.76e-03 | 182 | 83 | 4 | EFO_0006781 | |
| Disease | Huntington's disease (is_implicated_in) | 1.90e-03 | 23 | 83 | 2 | DOID:12858 (is_implicated_in) | |
| Disease | congenital diaphragmatic hernia (biomarker_via_orthology) | 2.07e-03 | 24 | 83 | 2 | DOID:3827 (biomarker_via_orthology) | |
| Disease | visual epilepsy (biomarker_via_orthology) | 2.11e-03 | 90 | 83 | 3 | DOID:11832 (biomarker_via_orthology) | |
| Disease | interstitial lung disease (is_marker_for) | 2.25e-03 | 25 | 83 | 2 | DOID:3082 (is_marker_for) | |
| Disease | visuospatial function measurement | 2.43e-03 | 26 | 83 | 2 | EFO_0803533 | |
| Disease | adult respiratory distress syndrome (is_marker_for) | 2.43e-03 | 26 | 83 | 2 | DOID:11394 (is_marker_for) | |
| Disease | chronic obstructive pulmonary disease (is_marker_for) | 2.62e-03 | 97 | 83 | 3 | DOID:3083 (is_marker_for) | |
| Disease | macular degeneration (is_implicated_in) | 2.62e-03 | 27 | 83 | 2 | DOID:4448 (is_implicated_in) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| AQEWGTGTPTEYSAF | 206 | A9YTQ3 | |
| TYTTLYERNRGSGSW | 321 | Q6ZRH7 | |
| DIAGTYYWHIPTGTT | 301 | Q92870 | |
| GSATGVTRYYPATPW | 251 | Q9NY47 | |
| WYIDSTGGTLHPYQL | 691 | Q8TDI0 | |
| GELLAYSWYAGPTLS | 46 | Q2WEN9 | |
| DSDGVSYPWYGNTTE | 106 | Q5VT40 | |
| SYPWYGNTTETVTLV | 111 | Q5VT40 | |
| WYLSITRPTSSYTGS | 21 | Q9Y5Z6 | |
| DIYYGIGPRTSWSTV | 336 | O94923 | |
| SGGNAGSYIPSYTSW | 226 | P56177 | |
| SWSDQTYPEGTQAIY | 36 | P08603 | |
| WITGHSYVTYGPLAN | 361 | Q9NR19 | |
| LGGTVYSLYSLGWAS | 61 | P24310 | |
| TSAQPTCDYGYGTWN | 21 | Q9ULX6 | |
| SPSWLGAAQNYYSPI | 66 | O94779 | |
| DYSQYSPWSCDTIGS | 806 | Q5TC82 | |
| VTPLSSGYALGSSNW | 211 | Q9NV88 | |
| GIDSSYYTGSLNWVP | 231 | P0DJD9 | |
| YYTGSLNWVPVTVEG | 236 | P0DJD9 | |
| GLSYNTTAFPNIWVG | 476 | Q9BY79 | |
| SPVWGEGSYLSSYPT | 231 | Q6ISU1 | |
| SGYNAWLSYELQPGT | 601 | Q9Y5H8 | |
| GSQLTWTYIAPQLGY | 266 | Q5VUB5 | |
| SVSSSYLSWYQQKPG | 51 | A0A0C4DH55 | |
| IGTPYRYNTSAGIWE | 396 | Q8NCM2 | |
| YIYNGHWDGLSASPS | 616 | P38570 | |
| YNYTSGAATGWPSMA | 251 | O60486 | |
| RIYILGGGTSWTAYS | 271 | Q6PID8 | |
| SLGGYPLAVRTYTWD | 376 | P21128 | |
| PITTGYTVKISNYGW | 66 | Q9HB71 | |
| GIDSSYYTGSLNWVP | 231 | P0DJD8 | |
| YYTGSLNWVPVTVEG | 236 | P0DJD8 | |
| SVSSYDRGQPYATEW | 346 | Q9BY11 | |
| YPAGWRTDSSNYSPV | 551 | P51178 | |
| LSYPWDGTQSYSLFN | 521 | Q9UBK2 | |
| SPSAWGNLYGAYVPS | 311 | Q96RI0 | |
| ASYYWSLTGPDIGVN | 136 | Q96BZ4 | |
| SGYNAWLSYELQPGT | 601 | Q9UN74 | |
| AAGTYYWHVPSGSTQ | 41 | O95704 | |
| AFGNYDPSGSTWLSA | 976 | Q6YHK3 | |
| SSYTPLPGSNYSEGW | 246 | P28068 | |
| YPISGSSLDWAYDLG | 356 | P15088 | |
| PTWNETLTYYGITDE | 191 | Q14184 | |
| YADQTYDGWVTTGPS | 671 | Q9HCG7 | |
| TYTWTPVNGTDYSLA | 606 | P54289 | |
| WTAPEALNYGRYSSE | 726 | P16591 | |
| SLSSSRSSYYGPWGR | 966 | Q9P0X4 | |
| GQWPGISDLSSDLYS | 776 | O15063 | |
| SATYSQGFTVWLGPI | 81 | Q9HCS2 | |
| ANEAPFYLWGSSTSG | 756 | O43303 | |
| SFPQGWSLGYQYPSS | 586 | Q7Z7F0 | |
| LGWNYVSTLASEGSY | 216 | Q14831 | |
| SGTIWSYPNPYTSIS | 2766 | Q8NDH2 | |
| TPSVGSQGDQWYLGY | 26 | A2RUR9 | |
| VTSYQLSAGYSRWPS | 481 | P37088 | |
| SPELYSATTWLGYVN | 361 | P35462 | |
| TLTWDSGNSEPVTYY | 336 | P10586 | |
| GIDSSYYTGSLNWVP | 231 | P0DJD7 | |
| YYTGSLNWVPVTVEG | 236 | P0DJD7 | |
| SNSYSYIWIGLHDPT | 96 | Q6UW15 | |
| YYSLIWQPVGAGTSG | 56 | P0DMQ5 | |
| WTAPEALNYGRYSSE | 726 | P07332 | |
| GNSYSYVWIGLHDPT | 96 | Q06141 | |
| SGLFGSIWAPQSDVY | 1531 | A2VDJ0 | |
| YSAGVLNDTWVSFPS | 451 | O75182 | |
| GYKSWTPQVGYSASS | 131 | O15457 | |
| TSPGNEGVIYSLSWA | 431 | Q8IZU2 | |
| WSPSSQFLAVGSYDG | 231 | Q9P2S5 | |
| SDGTPVNYTNWYRGE | 201 | Q8IWL1 | |
| SNGPLLSTVGSYDWA | 361 | P11215 | |
| AGYLGYTVTWLPSRQ | 401 | P20701 | |
| NRPGVYTLASSYASW | 266 | Q16651 | |
| SDGTPVNYTNWYRGE | 201 | Q8IWL2 | |
| SFGSSYSRVNYLTPW | 256 | Q6URK8 | |
| YTPSSVNGSLWEAGI | 336 | Q96Q45 | |
| WYSSGSRYQSAPSQA | 481 | Q86XZ4 | |
| SYWDTNPTRAQGYSG | 1046 | P07996 | |
| DSSLYTGQIYWAPVT | 231 | P20142 | |
| YPTGESLVYSNWAPG | 326 | P35247 | |
| NGTGPGIYSYRAWTS | 111 | Q5BIV9 | |
| GIYSYRAWTSGAGPT | 116 | Q5BIV9 | |
| AQLGPRSASYYAWSP | 556 | Q71H61 | |
| WYRQGITPSYPQGSS | 1056 | Q7Z6L1 | |
| SSWSQEYSFGPSAVL | 156 | Q8IX01 | |
| ETWTYLNSLYGGGPE | 871 | Q9Y2K6 | |
| GSGSPSYSLEIQWWY | 66 | Q96N03 | |
| LTAFGTYAGPVLWAS | 886 | Q5H8A4 | |
| TAPQGPGQSSYSYWV | 496 | Q9HD43 | |
| GTKVSAPYYSSWGTL | 131 | Q8N5A5 | |
| TVRLWPLYNYGDGTS | 1671 | Q562E7 | |
| SPSIGFSYSLGEAAW | 61 | Q9Y5A9 | |
| SVGLTGYGYTWIVPS | 246 | Q13224 |